Main Session
Sep
28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
2363 - Investigation of the 'New-PDL1' Delta Radiomic Signature for Identifying Chemo-Radiotherapy Patients Who May Benefit from Consolidation Immunotherapy
Presenter(s)

Andrea Filippi, MD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Lombardia